Mortality predictions and behavioral nudges by machine learning systems are associated with increased advance care planning utilization and reductions in high-acuity care. Researchers at the University of Pennsylvania recently studied the effectiveness of machine learning algorithms in identifying high-risk cancer patients nearing the last six months of life between June 17, 2019 and April 20, […]
Amedisys, Inc. (NASDAQ: AMED) is seeing glimmers of improvement on the labor pressures that contributed to uneven earnings performance during 2022. The company has reduced its nurse turnover rate to the vicinity of 20%, surpassing the industry average, Brian Tanquilut, equity analyst for the investment banking firm Jefferies Financial Group, indicated in a note. Jeffries […]
Through acquisitions and contracts with providers, more payers are going all-in on home-based care. The quest for cost reductions, often through risk-based models, is leading a rising number of insurance companies and other payers to make (sometimes) huge investments in the space. Among them is UnitedHealth Care (NYSE: UNH). These investments underscore the rising profile […]
Though buyers remain hungry for hospice acquisitions, smaller deals will likely be the most prevalent during 2023. Acquisition patterns established in 2021 and 2022 are shaping the M&A outlook for the current year. The number of hospice and home health deals fell by nearly a third last year, though a few “megadeals” have driven up […]
In 2022, the hospice community laid the groundwork for a transformational 2023. This year saw industry-changing acquisitions, some of the worst labor headwinds to date, the return of sequestration and a sometimes volatile national economy. During late 2021 and 2022, the U.S. Centers for Medicare & Medicaid Services (CMS) developed new approaches for enforcing hospice […]
Most hospices are sliding into 2023 between a rock and a hard place, beset by headwinds, labor shortages and questions with no easy answers. Through the cracks, providers can see glimmers of improvement. A number of hospice leaders anticipate that the industry will settle into a “new normal,” having absorbed the shock of the pandemic […]
Though hospice deal volume dipped in 2022 compared to previous years, five particular transactions could paint a larger picture of where investors see value in the space. These interesting, unusual or groundbreaking deals could signal what’s to come in 2023 and help shape the hospice market’s long-term future. Optum to pick up LHC Group Though […]
The anticipated acquisition of LHC Group (NASDAQ: LHCG) by the UnitedHealth Group (NYSE: UNH) subsidiary Optum is now expected to close during the first quarter of 2023. Optum in April announced its agreement to purchase the Lafayette, Louisiana-based home health and hospice provider for $5.5 billion. Initially expected to close this year, LHC Group today […]
Pennant Group reorganizes its executive team The Pennant Group, Inc. (NASDAQ: PNTG) recently began the hunt to fill CFO and chief investment officer roles. This follows the recent announcement that Derek Bunker has resigned as Pennant’s chief investment officer, executive vice president and corporate secretary, effective Dec. 31, 2022. “On behalf of the Pennant team, […]
Nashville-based HCA Healthcare Inc. (NYSE: HCA) and the University of Central Florida (UCF) recently added a new graduate fellowship in hospice and palliative care medicine to their existing repertoire of training programs. The program will accept two fellows annually. The fellowship will launch in July 2023 at HCA Florida Osceola Hospital, the Orlando VA Medical […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
